{"id":936727,"date":"2026-02-12T19:05:46","date_gmt":"2026-02-13T00:05:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/"},"modified":"2026-02-12T19:05:46","modified_gmt":"2026-02-13T00:05:46","slug":"caribou-biosciences-to-participate-in-upcoming-investor-conferences-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/","title":{"rendered":"Caribou Biosciences to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BERKELEY, Calif., Feb.  12, 2026  (GLOBE NEWSWIRE) &#8212; Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will participate in the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Citi 2026 Virtual Oncology Leadership Summit<\/strong>, Virtual<br \/>February 19, 2026, with a fireside chat at 10:45 AM ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Leerink Global Healthcare Conference, <\/strong>Miami, FL<br \/>March 10, 2026, with a fireside chat at 8:00 AM ET<br \/><a href=\"https:\/\/event.summitcast.com\/view\/mT9poctHDNthc6b89WqVjf\/guest_book?session_id=oDGi666VY8BTVHda7xriwg\" rel=\"nofollow\" target=\"_blank\">Webcast<\/a><\/li>\n<\/ul>\n<p>For more information and link to the Leerink webcast, please visit the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SPaZMolY_TVXXQJJCcVppcjUi5g5up-f-FwGVXELYFYMP24P_DVEK5Gn1B4YR_GkmtyNxO1Lzj-yfHVp8AKzxJblXztGJcN3Ok44HD94R6Gna3SxE5CcTvNbvjSebHxGjYcICxgYVZVY4zKSD_nRUc64pyNdmZ-9inO6OdWioM6ilOLydRxk-BD5om3hirY-fONrI3pVJBxEHO44oNUNek3YtXOmI8nGfjiuFKzBucooQXsxgUKTWCaAwvJET5Gs9lMBHE3JvULqtXtu6DcZYA==\" rel=\"nofollow\" target=\"_blank\">Events<\/a>\u00a0page on Caribou\u2019s website. The webcast will be available on the Caribou website for at least 30 days after the event.<\/p>\n<p>\n        <strong>About Caribou Biosciences, Inc.<\/strong><br \/>\n        <br \/>Caribou is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The Company\u2019s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. Caribou is focused on vispacabtagene regedleucel (vispa-cel) and CB-011 as off-the-shelf CAR-T cell therapies that have the potential to provide broad access and rapid treatment for patients with hematologic malignancies.\u00a0Follow the Company @CaribouBio and visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SDLqWli-gT0NSNWS4K5jYnW6LiDoqFcGMk5Y2g6EODmpM9fQBJL-4Dpk6Mf2HnP4K7kQiVxTz2mK-sxlliG8sLcq2BNU3y-Wz-6EJFD1_18=\" rel=\"nofollow\" target=\"_blank\">www.cariboubio.com<\/a>.<\/p>\n<p>\n        <strong>Caribou Biosciences, Inc. contacts:<\/strong><br \/>\n        <br \/>Peggy Vorwald, PhD<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lh0lvfdm60UnzRuAaLQy9issa0fC7gxzbmBkwx4psqWTqaDfhIVW3drPBzGGXW_2lCbAOWvY0l9FuHVEd0Nsn6cGgWga5d_WuML55colanctrT8RDoSGb6R-KNmXfWvYhqLaJiBK2tsJGJ2F-fEP7A==\" rel=\"nofollow\" target=\"_blank\">investor.relations@cariboubio.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yyjuOazB_RD2omQAMwK1Id7JFM6fUsjn_k832afn6JzcdR5gj1_mOiOCs5TsfDjrs2nVMFqR-adX7SxVeC_0GxmDHlcfXE2N239Uk0FPY1w=\" rel=\"nofollow\" target=\"_blank\">media@cariboubio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTE0NzlmZWQtNzA2OC00NGI4LTk1NzQtYmNkMzU0Y2M5MTZjLTEyMjEwNzYtMjAyNi0wMi0xMi1lbg==\/tiny\/Caribou-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BERKELEY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will participate in the following investor conferences: Citi 2026 Virtual Oncology Leadership Summit, VirtualFebruary 19, 2026, with a fireside chat at 10:45 AM ET Leerink Global Healthcare Conference, Miami, FLMarch 10, 2026, with a fireside chat at 8:00 AM ETWebcast For more information and link to the Leerink webcast, please visit the\u00a0Events\u00a0page on Caribou\u2019s website. The webcast will be available on the Caribou website for at least 30 days after the event. About Caribou Biosciences, Inc. Caribou is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The Company\u2019s genome-editing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Caribou Biosciences to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-936727","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Caribou Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Caribou Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BERKELEY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will participate in the following investor conferences: Citi 2026 Virtual Oncology Leadership Summit, VirtualFebruary 19, 2026, with a fireside chat at 10:45 AM ET Leerink Global Healthcare Conference, Miami, FLMarch 10, 2026, with a fireside chat at 8:00 AM ETWebcast For more information and link to the Leerink webcast, please visit the\u00a0Events\u00a0page on Caribou\u2019s website. The webcast will be available on the Caribou website for at least 30 days after the event. About Caribou Biosciences, Inc. Caribou is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The Company\u2019s genome-editing &hellip; Continue reading &quot;Caribou Biosciences to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-13T00:05:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Caribou Biosciences to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-02-13T00:05:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/\"},\"wordCount\":199,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/\",\"name\":\"Caribou Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=\",\"datePublished\":\"2026-02-13T00:05:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Caribou Biosciences to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Caribou Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/","og_locale":"en_US","og_type":"article","og_title":"Caribou Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"BERKELEY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will participate in the following investor conferences: Citi 2026 Virtual Oncology Leadership Summit, VirtualFebruary 19, 2026, with a fireside chat at 10:45 AM ET Leerink Global Healthcare Conference, Miami, FLMarch 10, 2026, with a fireside chat at 8:00 AM ETWebcast For more information and link to the Leerink webcast, please visit the\u00a0Events\u00a0page on Caribou\u2019s website. The webcast will be available on the Caribou website for at least 30 days after the event. About Caribou Biosciences, Inc. Caribou is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The Company\u2019s genome-editing &hellip; Continue reading \"Caribou Biosciences to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-13T00:05:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Caribou Biosciences to Participate in Upcoming Investor Conferences","datePublished":"2026-02-13T00:05:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/"},"wordCount":199,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/","name":"Caribou Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=","datePublished":"2026-02-13T00:05:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NDAzNiM3NDI0MjczIzIyMDk1MjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caribou-biosciences-to-participate-in-upcoming-investor-conferences-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Caribou Biosciences to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=936727"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936727\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=936727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=936727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=936727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}